Long-Term Use of Ticagrelor in Patients with Coronary Artery Disease.

about

Ticagrelor therapy and atrioventricular block: Do we need to worry?Dual Antiplatelet Therapy Duration: Reconciling the Inconsistencies.

P2860

Q33695952-950839DA-0ED3-4045-AC59-A7D71E8CD425 Q38635747-9ADAABB4-16F5-4068-82D8-5369E195A562

P2860

Long-Term Use of Ticagrelor in Patients with Coronary Artery Disease.

Item

http://www.wikidata.org/entity/Q39093174

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Long-Term Use of Ticagrelor in Patients with Coronary Artery Disease.

@en

Long-Term Use of Ticagrelor in Patients with Coronary Artery Disease.

@nl

type

Item

label

Long-Term Use of Ticagrelor in Patients with Coronary Artery Disease.

@en

Long-Term Use of Ticagrelor in Patients with Coronary Artery Disease.

@nl

prefLabel

Long-Term Use of Ticagrelor in Patients with Coronary Artery Disease.

@en

Long-Term Use of Ticagrelor in Patients with Coronary Artery Disease.

@nl

P1476

Long-Term Use of Ticagrelor in Patients with Coronary Artery Disease

@en

P2093

Sara Ariotti

http://www.w3.org/2001/XMLSchema#string

P2860

Duration of Dual Antiplatelet Therapy After Coronary Stenting: A Review of the Evidence

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention.

A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents.

Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial.

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevati

Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis.

Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials

P2888

s11886-017-0810-9

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11886-017-0810-9

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Marco Valgimigli

Giuseppe Gargiulo

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28097533

http://www.w3.org/2001/XMLSchema#string

Long-Term Use of Ticagrelor in Patients with Coronary Artery Disease.

about

P2860

P2860

Long-Term Use of Ticagrelor in Patients with Coronary Artery Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698